RC
PMVP icon

RBF Capital’s PMV Pharmaceuticals PMVP Stock Holding History

RBF Capital’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Hold
162,200
– – 0.01% 472
2026
Q1 		$201K Hold
162,200
– – 0.01% 460
2025
Q4 		$203K Sell
162,200
-83,361
-34% -$112K 0.01% 517
2025
Q3 		$344K Hold
245,561
– – 0.02% 448
2025
Q2 		$260K Hold
245,561
– – 0.01% 508
2025
Q1 		$268K Hold
245,561
– – 0.02% 478
2024
Q4 		$380K Sell
245,561
-7,800
-3% -$12.4K 0.02% 440
2024
Q3 		$388K Hold
253,361
– – 0.02% 458
2024
Q2 		$410K Buy
+253,361
New +$457K 0.02% 427

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

RBF Capital's PMVP Position: Q2 2026 in Review

RBF Capital held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 162,200 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #472.

RBF Capital first reported a position in PMVP in Q2 2024 and has held it in 9 quarters since. The position peaked at $410K in Q2 2024. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • RBF Capital held 162,200 shares of PMV Pharmaceuticals worth $217K as of Q2 2026.
  • RBF Capital left its PMV Pharmaceuticals share count unchanged in Q2 2026.
  • PMV Pharmaceuticals made up 0.01% of RBF Capital's portfolio in Q2 2026, its #472 holding.
  • RBF Capital first reported a position in PMV Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • RBF Capital's PMV Pharmaceuticals position peaked at $410K in Q2 2024.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.